Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3b, Open Label, Randomized, standard-of Care Control Arm, Multicenter, Superiority Study Evaluating the Efficacy, Safety, and Tolerability of Injectable CAB LA + RPV LA in Viremic Participants Living With HIV-1 (CROWN)

NCT06694805 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT06694805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06694805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3b, Open Label, Randomized, standard-of Care Control Arm, Multicenter, Superiority Study Evaluating the Efficacy, Safety, and Tolerability of Injectable CAB LA + RPV LA in Viremic Participants Living With HIV-1 (CROWN)
Lead sponsor
ViiV Healthcare
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 2, 2024
Completion date
June 9, 2028
Enrollment
326 (actual)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections